ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
4,024
Screening encounters
4,762
Diagnostic referrals
908
Outstanding pathways
324

Screening pathway

  1. Screening4,762Encounters
  2. Positive finding1,642Documented findings
  3. Referral908Diagnostic referrals
  4. Follow-up1,085Diagnostic visits
  5. Outcome584Resolved pathways

Stage totals use different units. Pending pathways: 324. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 0652 · EXP-0652Synthetic · Site A

Full participant history through 2026-12-22, across modalities and pathways.

  1. · Screening · VIA · Initial · Programme entry
  2. · Screening result · VIA · VIA positive · Adequate
  3. · Repeat plan · HPV DNA · Prior VIA positive · Scheduled for 2025-08-17
  4. · Diagnostic referral · EXP-0652-T-R
  5. · Contact attempt · Reached
  6. · Diagnostic booking · Initial booking
  7. · Barrier documented · Appointment coordination
  8. · Barrier documented · Contact difficulty
  9. · Diagnostic visit · Missed
  10. · Diagnostic booking · Rebooking
  11. · Navigation intervention · Coordination support
  12. · Diagnostic visit · Attended
  13. · Diagnosis · Colposcopy · Biopsy collected
  14. · Diagnosis · Histopathology · No high-grade lesion identified
  15. · Surveillance plan · HPV DNA · After clinical assessment · Scheduled for 2026-05-05
  16. · Follow-up disposition · Resolved · EXP-0652-T-R
  17. · Screening · HPV DNA · Repeat · Prior VIA positive
  18. · Screening result · HPV DNA · HPV not detected · Adequate
  19. · Surveillance · HPV DNA · Surveillance · After clinical assessment
  20. · Surveillance result · HPV DNA · HPV detected · Adequate

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Unresolved

Screened participants

4024 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-0983 · Expanded synthetic participant 0983Site B — Peri-Urban Access Programme
EXP-0984 · Expanded synthetic participant 0984Site C — Rural Outreach Programme
EXP-0986 · Expanded synthetic participant 0986Site E — Resource-Constrained Navigation Programme
EXP-0987 · Expanded synthetic participant 0987Site A — Urban Referral Hub
EXP-0988 · Expanded synthetic participant 0988Site D — Community Engagement Programme
EXP-0989 · Expanded synthetic participant 0989Site D — Community Engagement Programme
EXP-0992 · Expanded synthetic participant 0992Site B — Peri-Urban Access Programme
EXP-0993 · Expanded synthetic participant 0993Site B — Peri-Urban Access Programme
EXP-0994 · Expanded synthetic participant 0994Site C — Rural Outreach Programme
EXP-0995 · Expanded synthetic participant 0995Site B — Peri-Urban Access Programme
EXP-0996 · Expanded synthetic participant 0996Site D — Community Engagement Programme
EXP-0997 · Expanded synthetic participant 0997Site D — Community Engagement Programme
EXP-0998 · Expanded synthetic participant 0998Site C — Rural Outreach Programme
EXP-0999 · Expanded synthetic participant 0999Site E — Resource-Constrained Navigation Programme
EXP-1000 · Expanded synthetic participant 1000Site E — Resource-Constrained Navigation Programme
EXP-1001 · Expanded synthetic participant 1001Site E — Resource-Constrained Navigation Programme
EXP-1002 · Expanded synthetic participant 1002Site A — Urban Referral Hub
EXP-1003 · Expanded synthetic participant 1003Site C — Rural Outreach Programme
EXP-1005 · Expanded synthetic participant 1005Site D — Community Engagement Programme
EXP-1006 · Expanded synthetic participant 1006Site E — Resource-Constrained Navigation Programme
EXP-1009 · Expanded synthetic participant 1009Site E — Resource-Constrained Navigation Programme
EXP-1010 · Expanded synthetic participant 1010Site A — Urban Referral Hub
EXP-1012 · Expanded synthetic participant 1012Site D — Community Engagement Programme
EXP-1013 · Expanded synthetic participant 1013Site D — Community Engagement Programme
EXP-1014 · Expanded synthetic participant 1014Site B — Peri-Urban Access Programme

Programme insights

Encounters by modality

VIA
1813
HPV DNA
2278
Cytology
671

Navigation activity

Barrier documented
812
Contact attempt
1334
Navigation intervention
351
Diagnostic booking
1134
Diagnostic visit
1085

Documented barriers

Contact difficulty
259
Transport difficulty
267
Appointment coordination
286

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.